CBIO Catalyst Biosciences Inc

Catalyst Biosciences Inc is a clinical-stage biopharmaceutical company. The Company is engaged in creating and developing novel medicines to address serious medical conditions.

As of 10/26/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  04/12/2006
Outstanding shares:  31,365,701
Average volume:  343,672
Market cap:   $108,838,982
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    14888D208
ISIN:        US14888D2080
Valuation   (See tab for details)
PE ratio:   -1.39
PB ratio:   1.26
PS ratio:   19.71
Return on equity:   -90.77%
Net income %:   -1,399.71%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy